US FDA approves Eli Lilly's therapy for metastatic breast cancer-February 2024-www.financetom.com

US FDA approves Eli Lilly's therapy for metastatic breast cancer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Eli Lilly's therapy for metastatic breast cancer

Sep 25, 2025 11:20 AM

Sept 25 (Reuters) - Eli Lilly ( LLY ) said on Thursday

that the U.S. Food and Drug Administration has approved its

therapy for the treatment of metastatic breast cancer in

patients whose disease progressed after at least one line of

endocrine therapy.

Previous page： Ardurra Expands California Water Expertise with Acquisition of MKN & Associates Next page： LifeMD Offers Lower Cash-Pay Price for Novo Nordisk's Wegovy, Ozempic

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ardurra Expands California Water Expertise with Acquisition of MKN & Associates

Nov 17, 2025

MIAMI--(BUSINESS WIRE)-- Ardurra Group, Inc. (Ardurra), a nationally recognized engineering and consulting firm, is pleased to announce the acquisition of MKN & Associates, Inc. (MKN), a respected California-based firm specializing in water and wastewater engineering services for municipalities and government agencies. Ardurra, ranked #75 on Engineering News-Record’s (ENR) Top 500 Design Firms list and consistently among the top 20 firms...

LifeMD Offers Lower Cash-Pay Price for Novo Nordisk's Wegovy, Ozempic

Nov 17, 2025

10:08 AM EST, 11/17/2025 (MT Newswires) -- LifeMD ( LFMD ) said Monday it will offer the 0.25 milligram and 0.5 milligram doses of Novo Nordisk's ( NVO ) GLP-1 drugs Wegovy and Ozempic at a cash-pay price of $199 a month for two fills for new patients. Novo Nordisk ( NVO ) said earlier Monday that the medications are...

Brunswick Exploration Reports Strong Lithium Intercepts at Anatacau Main

Nov 17, 2025

10:09 AM EST, 11/17/2025 (MT Newswires) -- Brunswick Exploration ( BRWXF ) said Monday that all drillholes from its Anatacau Main project, located in the Eeyou Istchee-James Bay region of Quebec, were centered on the Anais showing and intercepted multiple, large spodumene-bearing pegmatites with rich lithium mineralization. The company said highlights included 1.66% lithium oxide (Li2O) over 47.2 meters in...

Hims & Hers Health Approves $250 Million Share Buyback Plan

Nov 17, 2025

10:09 AM EST, 11/17/2025 (MT Newswires) -- Hims & Hers Health ( HIMS ) said Monday its board approved a share buyback program of up to $250 million of its class A common shares over the next three years. The program follows the completion of a $100 million buyback plan set up in July 2024, which has now been fully...